Marie-Christine Bissery

Oncology specialist

Skills and experience

Dr. Marie-Christine Bissery is the Chief Scientific Officer at Cureteq AG. Cureteq is a biotechnology and asset management company developing new innovative medicines based on a sophisticated artificial intelligence (AI) platform. Cureteq leverages AI to identify the optimal applications of a given molecule and to devise optimized and de-risked clinical development plans. Dr. Marie-Christine Bissery has over thirty years of pharmaceutical, biotech, and academic experience in preclinical and early clinical research with a main focus in oncology. She spent ten years in Biotech as CSO and CDO at Genticel and Novintum. She is also a Research and Development Advisor for Oncology Biotechs and Investment Funds.


Dr. Marie-Christine Bissery holds a PhD, and Master’s degree in Pharmaceutical Sciences and a Doctorate in Pharmacy from University of Paris XI, France. She is also extensively published and patented.